TPD52 and NFKB1 gene expression levels correlate with G2 chromosomal radiosensitivity in lymphocytes of women with and at risk of hereditary breast cancer.
AuthorsSims, Andrew H
Miller, Crispin J
Scott, David A
Clarke, Robert B
AffiliationBreast Biology Group, Paterson Institute for Cancer Research, University of Manchester, UK. Andrew.H.Sims@manchester.ac.uk
MetadataShow full item record
AbstractPURPOSE: To evaluate a transcriptomic approach to identify healthy women at increased risk of breast cancer due to G2-radiosensitivity and look at transcripts that are differentially expressed between individuals. MATERIALS AND METHODS: We perform the first study to assess the association of G2 radiosensitivity with basal gene expression in cultured T-lymphocytes from 11 women with breast cancer and 12 healthy female relatives using Affymetrix GeneChips. RESULTS: Transcripts associated with radiosensitivity and breast cancer risk were predominantly involved in innate immunity and inflammation, such as interleukins and chemokines. Genes differentially expressed in radiosensitive individuals were more similarly expressed in close family members than in un-related individuals, suggesting heritability of the trait. The expression of tumour protein D52 (TPD52), a gene implicated in cell proliferation, apoptosis, and vesicle trafficking was the most strongly correlated with G2 score while nuclear factor (kappa)-B (NFKB1) was highly inversely correlated with G2 score. NFKB1 is known to be activated by irradiation and its inhibition has been previously shown to increase radiosensitivity. CONCLUSIONS: Gene expression analysis of lymphocytes may provide a quantitative measure of radiation response potential and is a promising marker of breast cancer susceptibility.
CitationTPD52 and NFKB1 gene expression levels correlate with G2 chromosomal radiosensitivity in lymphocytes of women with and at risk of hereditary breast cancer. 2007, 83 (6):409-20 Int. J. Radiat. Biol.
JournalInternational Journal of Radiation Biology
- G2-checkpoint abrogation in irradiated lymphocytes: A new cytogenetic approach to assess individual radiosensitivity and predisposition to cancer.
- Authors: Terzoudi GI, Hatzi VI, Barszczewska K, Manola KN, Stavropoulou C, Angelakis P, Pantelias GE
- Issue date: 2009 Nov
- Chromosomal radiosensitivity in Ukrainian breast cancer patients and healthy individuals.
- Authors: Ryabchenko NM, Glavin OA, Shtefura VV, Anikushko MF
- Issue date: 2012 Jul
- Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition.
- Authors: Baeyens A, Thierens H, Claes K, Poppe B, Messiaen L, De Ridder L, Vral A
- Issue date: 2002 Dec 2
- Topoisomerase IIα levels and G2 radiosensitivity in T-lymphocytes of women presenting with breast cancer.
- Authors: Bryant PE, Riches AC, Shovman O, Dewar JA, Adamson DJ
- Issue date: 2012 Nov
- The potential role of G2- but not of G0-radiosensitivity for predisposition of prostate cancer.
- Authors: Borgmann K, Raabe A, Reuther S, Szymczak S, Schlomm T, Isbarn H, Gomolka M, Busjahn A, Bonin M, Ziegler A, Dikomey E
- Issue date: 2010 Jul